Elon Musk bungles his criticism of U.S. drug regulators

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

While barnstorming across Pennsylvania recently in support of Donald Trump’s presidential campaign, Elon Musk criticized the U.S. government for issuing too many rules and regulations. But in a twist on Musk’s familiar lament, he cited the FDA and a cancer drug called Welireg, not rockets, electric cars, or satellites. 

advertisement

Earlier this year, the mother of a friend took Welireg in a clinical trial and it cured her brain cancer, Musk explained while on stage at a town hall meeting.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe